Mauritian Cynomolgus Macaques Share Two Exceptionally Common Major Histocompatibility Complex Class I Alleles That Restrict Simian Immunodeficiency Virus-Specific CD8+ T Cells

ABSTRACT Vaccines that elicit CD8+ T-cell responses are routinely tested for immunogenicity in nonhuman primates before advancement to clinical trials. Unfortunately, the magnitude and specificity of vaccine-elicited T-cell responses are variable in currently utilized nonhuman primate populations, owing to heterogeneity in major histocompatibility (MHC) class I genetics. We recently showed that Mauritian cynomolgus macaques (MCM) have unusually simple MHC genetics, with three common haplotypes encoding a shared pair of MHC class IA alleles, Mafa-A*25 and Mafa-A*29. Based on haplotype frequency, we hypothesized that CD8+ T-cell responses restricted by these MHC class I alleles would be detected in nearly all MCM. We examine here the frequency and functionality of these two alleles, showing that 88% of MCM express Mafa-A*25 and Mafa-A*29 and that animals carrying these alleles mount three newly defined simian immunodeficiency virus-specific CD8+ T-cell responses. The epitopes recognized by each of these responses accumulated substitutions consistent with immunologic escape, suggesting these responses exert antiviral selective pressure. The demonstration that Mafa-A*25 and Mafa-A*29 restrict CD8+ T-cell responses that are shared among nearly all MCM indicates that these animals are an advantageous nonhuman primate model for comparing the immunogenicity of vaccines that elicit CD8+ T-cell responses.

[1]  D. O’Connor,et al.  MHC haplotype frequencies in a UK breeding colony of Mauritian cynomolgus macaques mirror those found in a distinct population from the same geographic origin , 2009, Journal of medical primatology.

[2]  A. Hughes,et al.  Characterization of 47 MHC class I sequences in Filipino cynomolgus macaques , 2009, Immunogenetics.

[3]  Donald K Carter,et al.  HIV-1 vaccine-induced immunity in the test-of-concept Step Study: a case–cohort analysis , 2008, The Lancet.

[4]  Devan V Mehrotra,et al.  Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial , 2008, The Lancet.

[5]  Morten Nielsen,et al.  MHC motif viewer , 2008, Immunogenetics.

[6]  R. Stebbings,et al.  Resistance to superinfection by a vigorously replicating, uncloned stock of simian immunodeficiency virus (SIVmac251) stimulates replication of a live attenuated virus vaccine (SIVmacC8). , 2008, The Journal of general virology.

[7]  D. O’Connor,et al.  Comparative study of Tat vaccine regimens in Mauritian cynomolgus and Indian rhesus macaques: influence of Mauritian MHC haplotypes on susceptibility/resistance to SHIV(89.6P) infection. , 2008, Vaccine.

[8]  A. Hughes,et al.  MHC class I characterization of Indonesian cynomolgus macaques , 2008, Immunogenetics.

[9]  R. Sékaly The failed HIV Merck vaccine study: a step back or a launching point for future vaccine development? , 2008, The Journal of experimental medicine.

[10]  R. Steinbrook One step forward, two steps back--will there ever be an AIDS vaccine? , 2007, The New England journal of medicine.

[11]  M. Carrington,et al.  The Major Histocompatibility Complex Class II Alleles Mamu-DRB1*1003 and -DRB1*0306 Are Enriched in a Cohort of Simian Immunodeficiency Virus-Infected Rhesus Macaque Elite Controllers , 2007, Journal of Virology.

[12]  M. Carrington,et al.  Mamu-B*08-Positive Macaques Control Simian Immunodeficiency Virus Replication , 2007, Journal of Virology.

[13]  A. Tosi,et al.  Comparative phylogenetics offer new insights into the biogeographic history of Macaca fascicularis and the origin of the Mauritian macaques. , 2007, Molecular phylogenetics and evolution.

[14]  D. Watkins,et al.  Subdominant CD8+ T-Cell Responses Are Involved in Durable Control of AIDS Virus Replication , 2007, Journal of Virology.

[15]  C. Snowdon The monkey wars , 1996, International Journal of Primatology.

[16]  D. Watkins,et al.  Beyond Mamu-A*01+ Indian Rhesus Macaques: Continued Discovery of New MHC Class I Molecules that Bind Epitopes from the Simian AIDS Viruses , 2007 .

[17]  D. Watkins,et al.  The Antiviral Efficacy of Simian Immunodeficiency Virus-Specific CD8+ T Cells Is Unrelated to Epitope Specificity and Is Abrogated by Viral Escape , 2006, Journal of Virology.

[18]  I. Macchia,et al.  Identification of a cytotoxic T-lymphocyte (CTL) epitope recognized by Gag-specific CTLs in cynomolgus monkeys infected with simian/human immunodeficiency virus. , 2006, The Journal of general virology.

[19]  D. O’Connor,et al.  Simian Immunodeficiency Virus SIVmac239 Infection of Major Histocompatibility Complex-Identical Cynomolgus Macaques from Mauritius , 2006, Journal of Virology.

[20]  M. Carrington,et al.  The High-Frequency Major Histocompatibility Complex Class I Allele Mamu-B*17 Is Associated with Control of Simian Immunodeficiency Virus SIVmac239 Replication , 2006, Journal of Virology.

[21]  Austin L. Hughes,et al.  Unusually High Frequency MHC Class I Alleles in Mauritian Origin Cynomolgus Macaques , 2005, The Journal of Immunology.

[22]  D. Montefiori,et al.  Effect of CD8+ Lymphocyte Depletion on Virus Containment after Simian Immunodeficiency Virus SIVmac251 Challenge of Live Attenuated SIVmac239Δ3-Vaccinated Rhesus Macaques , 2005, Journal of Virology.

[23]  J. Mascola,et al.  Pathogenicity of Simian-Human Immunodeficiency Virus SHIV-89.6P and SIVmac Is Attenuated in Cynomolgus Macaques and Associated with Early T-Lymphocyte Responses , 2005, Journal of Virology.

[24]  A. Yamada,et al.  Detection of 14 alleles derived from the MHC class I A locus in cynomolgus monkeys , 2004, Immunogenetics.

[25]  James Robinson,et al.  IMGT/HLA and IMGT/MHC: sequence databases for the study of the major histocompatibility complex , 2003, Nucleic Acids Res..

[26]  Todd M. Allen,et al.  Escape in One of Two Cytotoxic T-Lymphocyte Epitopes Bound by a High-Frequency Major Histocompatibility Complex Class I Molecule, Mamu-A*02: a Paradigm for Virus Evolution and Persistence? , 2002, Journal of Virology.

[27]  M. Krawczak,et al.  MHC Class I Alleles Influence Set-Point Viral Load and Survival Time in Simian Immunodeficiency Virus-Infected Rhesus Monkeys1 , 2002, The Journal of Immunology.

[28]  J. Heeney,et al.  Comparison of early plasma RNA loads in different macaque species and the impact of different routes of exposure on SIV/SHIV infection , 2001, Journal of medical primatology.

[29]  Todd M. Allen,et al.  CD8+ Lymphocytes from Simian Immunodeficiency Virus-Infected Rhesus Macaques Recognize 14 Different Epitopes Bound by the Major Histocompatibility Complex Class I Molecule Mamu-A*01: Implications for Vaccine Design and Testing , 2001, Journal of Virology.

[30]  W. Hildebrand,et al.  C-terminal epitope tagging facilitates comparative ligand mapping from MHC class I positive cells. , 2000, Human immunology.

[31]  John Sidney,et al.  Definition of the Mamu A*01 Peptide Binding Specificity: Application to the Identification of Wild-Type and Optimized Ligands from Simian Immunodeficiency Virus Regulatory Proteins1 , 2000, The Journal of Immunology.

[32]  D. Ho,et al.  Enhanced Infectivity of an R5-Tropic Simian/Human Immunodeficiency Virus Carrying Human Immunodeficiency Virus Type 1 Subtype C Envelope after Serial Passages in Pig-Tailed Macaques (Macaca nemestrina) , 2000, Journal of Virology.

[33]  A. Perelson,et al.  Effects of in Vivo Cd8+ T Cell Depletion on Virus Replication in Rhesus Macaques Immunized with a Live, Attenuated Simian Immunodeficiency Virus Vaccine , 2000, The Journal of experimental medicine.

[34]  M. Aidoo,et al.  Field studies of cytotoxic T lymphocytes in malaria infections: implications for malaria vaccine development. , 2000, Parasitology today.

[35]  S O'Brien,et al.  New class I and II HLA alleles strongly associated with opposite patterns of progression to AIDS. , 1999, Journal of immunology.

[36]  Todd M. Allen,et al.  Characterization of the peptide binding motif of a rhesus MHC class I molecule (Mamu-A*01) that binds an immunodominant CTL epitope from simian immunodeficiency virus. , 1998, Journal of immunology.

[37]  H. Clifford Lane,et al.  Administration of an Anti-CD8 Monoclonal Antibody Interferes with the Clearance of Chimeric Simian/Human Immunodeficiency Virus during Primary Infections of Rhesus Macaques , 1998, Journal of Virology.

[38]  Hans-Georg Rammensee,et al.  MHC Ligands and Peptide Motifs , 1998, Molecular Biology Intelligence Unit.

[39]  J. Goedert,et al.  Influence of combinations of human major histocompatibility complex genes on the course of HIV–1 infection , 1996, Nature Medicine.

[40]  R. Sussman,et al.  Mitochondrial DNA of the Mauritian macaques (Macaca fascicularis): an example of the founder effect. , 1995, American journal of physical anthropology.

[41]  G. Shaw,et al.  Virus-specific CD8+ cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection , 1994, Journal of virology.

[42]  D. Ho,et al.  Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome , 1994, Journal of virology.

[43]  N. Letvin,et al.  Simian immunodeficiency virus-specific CD8+ lymphocyte response in acutely infected rhesus monkeys , 1993, Journal of virology.

[44]  F. Gao,et al.  Human infection by genetically diverse SIVSM-related HIV-2 in West Africa , 1992, Nature.

[45]  J. Broderson,et al.  Susceptibility of Macaca fascicularis monkeys from Mauritius to different species of Plasmodium. , 1992, The Journal of parasitology.

[46]  R. Demars,et al.  Production of human cells expressing individual transferred HLA-A,-B,-C genes using an HLA-A,-B,-C null human cell line. , 1989, Journal of immunology.

[47]  R. Desrosiers,et al.  Comparison of simian immunodeficiency virus isolates , 1988, Nature.

[48]  R. Desrosiers,et al.  Simian models for AIDS. , 1987, Cancer detection and prevention. Supplement : official publication of the International Society for Preventive Oncology, Inc.

[49]  H. Orr,et al.  Transfer of cloned human class I major histocompatibility complex genes into HLA mutant human lymphoblastoid cells , 1986, Molecular and cellular biology.

[50]  Gordon A. Harrison,et al.  Unity in diversity. The short life of the United Oxford Hospitals , 1979, Medical History.